Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
- Attruby is the first and only approved product with aspecifying near-complete stabilization of TTR. Attruby has been…
- Attruby is the first and only approved product with aspecifying near-complete stabilization of TTR. Attruby has been…
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each…
AMSTERDAM, Nov. 19, 2024 /PRNewswire/ -- The 2024 Access to Medicine Index finds that pharmaceutical companies are not fully leveraging…
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its two global winners, each receiving £30,000 for solving…
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its two global winners, each receiving £30,000 for solving…
NEW DELHI, Nov. 14, 2024 /PRNewswire/ -- The James Dyson Award unveils its two global winners, each receiving £30,000 for solving…
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…